Condition

Herpes Zoster

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 15 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting2
Common interventions17
Lead sponsors shown11
Advertisement

Clinical trials

15 shown
A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in FinlandNCT07502560 · 2026-03-31
RECRUITING
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control PopulationNCT05580458 · 2023-03-13
RECRUITING
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01
COMPLETED
HIV Indicator Diseases in Hospital and Primary CareNCT05225493 · 2020-01-01
UNKNOWN
Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic PatientsNCT03016884 · 2017-01-01
UNKNOWN
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoNCT02902822 · 2016-10-01
COMPLETED
Postherpetic Neuralgia After Herpes Zoster and Incident Dementia RiskNCT07399288 · 2015-10-01
COMPLETED
The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using AbataceptNCT03604406 · 2014-05-08
COMPLETED
Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-StudyNCT01213810 · 2010-12-01
WITHDRAWN
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected SubjectsNCT01165203 · 2010-09-30
COMPLETED
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral TherapyNCT00851786 · 2009-04-29
COMPLETED
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)NCT00233155 · 2005-08-01
COMPLETED
Dextromethorphan Versus Placebo for Neuropathic PainNCT00001344 · 1993-03-01
COMPLETED
Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainNCT00082316
COMPLETED
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainNCT00089557
TERMINATED

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

Trial status mix

COMPLETED9
RECRUITING2
UNKNOWN2
TERMINATED1
WITHDRAWN1

Phase mix

PHASE29
PHASE12
PHASE42
NA1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.